The Dawn of Curative Strategies: Analyzing the Pipeline of Gene Therapy and Immunomodulators for HSV Latency.
The current standard of care for Herpes Simplex Virus (HSV) focuses predominantly on managing acute outbreaks and preventing recurrence through suppressive therapy. While highly effective at reducing symptoms and transmission risk, existing antiviral medications do not eradicate the virus. The core challenge for drug developers lies in targeting the **latent** virus, which hides silently within...
0 Comments 0 Shares 530 Views 0 Reviews
Sponsored

Real Profits Start Here – Try Stockity Today!

Experience fast and simple online trading with Stockity. Learn, practice, and trade with real-time market tools designed for everyone — beginners to pros.